1 Scope of the Report 1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Human Vaccine Consumption 2016-2026 2.1.2 Human Vaccine Consumption CAGR by Region 2.2 Human Vaccine Segment by Type 2.2.1 Varicella 2.2.2 Influenza 2.2.3 Polio 2.2.4 Hepatitis A 2.2.5 Rabies 2.2.6 BCG 2.2.7 Hepatitis B 2.2.8 Pertussis, Diphtheria, Tetanus 2.2.9 Pneumococcal 2.2.10 Rota vaccine 2.3 Human Vaccine Sales by Type 2.3.1 Global Human Vaccine Sales Market Share by Type (2016-2021) 2.3.2 Global Human Vaccine Revenue and Market Share by Type (2016-2021) 2.3.3 Global Human Vaccine Sale Price by Type (2016-2021) 2.4 Human Vaccine Segment by Application 2.4.1 Adults 2.4.2 Children 2.5 Human Vaccine Sales by Application 2.5.1 Global Human Vaccine Sale Market Share by Application (2016-2021) 2.5.2 Global Human Vaccine Revenue and Market Share by Application (2016-2021) 2.5.3 Global Human Vaccine Sale Price by Application (2016-2021) 3 Global Human Vaccine by Company 3.1 Global Human Vaccine Sales Market Share by Company 3.1.1 Global Human Vaccine Sales by Company (2019-2021) 3.1.2 Global Human Vaccine Sales Market Share by Company (2019-2021) 3.2 Global Human Vaccine Revenue Market Share by Company 3.2.1 Global Human Vaccine Revenue by Company (2019-2021) 3.2.2 Global Human Vaccine Revenue Market Share by Company (2019-2021) 3.3 Global Human Vaccine Sale Price by Company 3.4 Global Manufacturers Human Vaccine Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Human Vaccine Product Location Distribution 3.4.2 Players Human Vaccine Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 Human Vaccine by Region 4.1 Global Human Vaccine by Region 4.1.1 Global Human Vaccine Sales by Region 4.1.2 Global Human Vaccine Revenue by Region 4.2 Americas Human Vaccine Sales Growth 4.3 APAC Human Vaccine Sales Growth 4.4 Europe Human Vaccine Sales Growth 4.5 Middle East & Africa Human Vaccine Sales Growth 5 Americas 5.1 Americas Human Vaccine Sales by Country 5.1.1 Americas Human Vaccine Sales by Country (2016-2021) 5.1.2 Americas Human Vaccine Revenue by Country (2016-2021) 5.2 Americas Human Vaccine Sales by Type 5.3 Americas Human Vaccine Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Human Vaccine Sales by Region 6.1.1 APAC Human Vaccine Sales by Region (2016-2021) 6.1.2 APAC Human Vaccine Revenue by Region (2016-2021) 6.2 APAC Human Vaccine Sales by Type 6.3 APAC Human Vaccine Sales by Application 6.4 China 6.5 Japan 6.6 Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 7 Europe 7.1 Europe Human Vaccine by Country 7.1.1 Europe Human Vaccine Sales by Country (2016-2021) 7.1.2 Europe Human Vaccine Revenue by Country (2016-2021) 7.2 Europe Human Vaccine Sales by Type 7.3 Europe Human Vaccine Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Human Vaccine by Country 8.1.1 Middle East & Africa Human Vaccine Sales by Country (2016-2021) 8.1.2 Middle East & Africa Human Vaccine Revenue by Country (2016-2021) 8.2 Middle East & Africa Human Vaccine Sales by Type 8.3 Middle East & Africa Human Vaccine Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Country 9 Market Drivers, Challenges and Trends 9.1 Market Drivers and Impact 9.1.1 Growing Demand from Key Regions 9.1.2 Growing Demand from Key Applications and Potential Industries 9.2 Market Challenges and Impact 9.3 Market Trends 10 Marketing, Distributors and Customer 10.1 Sales Channel 10.1.1 Direct Channels 10.1.2 Indirect Channels 10.2 Human Vaccine Distributors 10.3 Human Vaccine Customer 11 Global Human Vaccine Market Forecast 11.1 Global Human Vaccine Forecast by Region 11.1.1 Global Human Vaccine Forecast by Regions (2021-2026) 11.2.2 Global Human Vaccine Revenue Forecast by Regions (2021-2026) 11.2 Americas Forecast by Country 11.3 APAC Forecast by Region 11.4 Europe Forecast by Country 11.5 Middle East & Africa Forecast by Country 11.6 Global Human Vaccine Forecast by Type 11.7 Global Human Vaccine Forecast by Application 12 Key Players Analysis 12.1 CNBG 12.1.1 CNBG Company Information 12.1.2 CNBG Human Vaccine Product Offered 12.1.3 CNBG Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.1.4 CNBG Main Business Overview 12.1.5 CNBG Latest Developments 12.2 Changsheng Life 12.2.1 Changsheng Life Company Information 12.2.2 Changsheng Life Human Vaccine Product Offered 12.2.3 Changsheng Life Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.2.4 Changsheng Life Main Business Overview 12.2.5 Changsheng Life Latest Developments 12.3 Zhifei 12.3.1 Zhifei Company Information 12.3.2 Zhifei Human Vaccine Product Offered 12.3.3 Zhifei Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.3.4 Zhifei Main Business Overview 12.3.5 Zhifei Latest Developments 12.4 ChengDa Bio 12.4.1 ChengDa Bio Company Information 12.4.2 ChengDa Bio Human Vaccine Product Offered 12.4.3 ChengDa Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.4.4 ChengDa Bio Main Business Overview 12.4.5 ChengDa Bio Latest Developments 12.5 Kangtai 12.5.1 Kangtai Company Information 12.5.2 Kangtai Human Vaccine Product Offered 12.5.3 Kangtai Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.5.4 Kangtai Main Business Overview 12.5.5 Kangtai Latest Developments 12.6 SINOVAC BIOTECH 12.6.1 SINOVAC BIOTECH Company Information 12.6.2 SINOVAC BIOTECH Human Vaccine Product Offered 12.6.3 SINOVAC BIOTECH Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.6.4 SINOVAC BIOTECH Main Business Overview 12.6.5 SINOVAC BIOTECH Latest Developments 12.7 Hissen 12.7.1 Hissen Company Information 12.7.2 Hissen Human Vaccine Product Offered 12.7.3 Hissen Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.7.4 Hissen Main Business Overview 12.7.5 Hissen Latest Developments 12.8 Walvax Biotechnology 12.8.1 Walvax Biotechnology Company Information 12.8.2 Walvax Biotechnology Human Vaccine Product Offered 12.8.3 Walvax Biotechnology Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.8.4 Walvax Biotechnology Main Business Overview 12.8.5 Walvax Biotechnology Latest Developments 12.9 GSK 12.9.1 GSK Company Information 12.9.2 GSK Human Vaccine Product Offered 12.9.3 GSK Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.9.4 GSK Main Business Overview 12.9.5 GSK Latest Developments 12.10 SANOFI 12.10.1 SANOFI Company Information 12.10.2 SANOFI Human Vaccine Product Offered 12.10.3 SANOFI Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.10.4 SANOFI Main Business Overview 12.10.5 SANOFI Latest Developments 12.11 Rong An 12.11.1 Rong An Company Information 12.11.2 Rong An Human Vaccine Product Offered 12.11.3 Rong An Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.11.4 Rong An Main Business Overview 12.11.5 Rong An Latest Developments 12.12 NuoCheng Bio 12.12.1 NuoCheng Bio Company Information 12.12.2 NuoCheng Bio Human Vaccine Product Offered 12.12.3 NuoCheng Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.12.4 NuoCheng Bio Main Business Overview 12.12.5 NuoCheng Bio Latest Developments 12.13 Hualan Bio 12.13.1 Hualan Bio Company Information 12.13.2 Hualan Bio Human Vaccine Product Offered 12.13.3 Hualan Bio Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.13.4 Hualan Bio Main Business Overview 12.13.5 Hualan Bio Latest Developments 12.14 Tiantan biological 12.14.1 Tiantan biological Company Information 12.14.2 Tiantan biological Human Vaccine Product Offered 12.14.3 Tiantan biological Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.14.4 Tiantan biological Main Business Overview 12.14.5 Tiantan biological Latest Developments 12.15 Changchun Baike 12.15.1 Changchun Baike Company Information 12.15.2 Changchun Baike Human Vaccine Product Offered 12.15.3 Changchun Baike Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.15.4 Changchun Baike Main Business Overview 12.15.5 Changchun Baike Latest Developments 12.16 Adimmune 12.16.1 Adimmune Company Information 12.16.2 Adimmune Human Vaccine Product Offered 12.16.3 Adimmune Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.16.4 Adimmune Main Business Overview 12.16.5 Adimmune Latest Developments 12.17 Zhongyianke Biotech 12.17.1 Zhongyianke Biotech Company Information 12.17.2 Zhongyianke Biotech Human Vaccine Product Offered 12.17.3 Zhongyianke Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.17.4 Zhongyianke Biotech Main Business Overview 12.17.5 Zhongyianke Biotech Latest Developments 12.18 Bharat Biotech 12.18.1 Bharat Biotech Company Information 12.18.2 Bharat Biotech Human Vaccine Product Offered 12.18.3 Bharat Biotech Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.18.4 Bharat Biotech Main Business Overview 12.18.5 Bharat Biotech Latest Developments 12.19 Bavarian Nordic 12.19.1 Bavarian Nordic Company Information 12.19.2 Bavarian Nordic Human Vaccine Product Offered 12.19.3 Bavarian Nordic Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.19.4 Bavarian Nordic Main Business Overview 12.19.5 Bavarian Nordic Latest Developments 12.20 Sanofi-Pasteur 12.20.1 Sanofi-Pasteur Company Information 12.20.2 Sanofi-Pasteur Human Vaccine Product Offered 12.20.3 Sanofi-Pasteur Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.20.4 Sanofi-Pasteur Main Business Overview 12.20.5 Sanofi-Pasteur Latest Developments 12.21 Indian Immunologicals 12.21.1 Indian Immunologicals Company Information 12.21.2 Indian Immunologicals Human Vaccine Product Offered 12.21.3 Indian Immunologicals Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.21.4 Indian Immunologicals Main Business Overview 12.21.5 Indian Immunologicals Latest Developments 12.22 KANGH 12.22.1 KANGH Company Information 12.22.2 KANGH Human Vaccine Product Offered 12.22.3 KANGH Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.22.4 KANGH Main Business Overview 12.22.5 KANGH Latest Developments 12.23 Henan Grand Biopharma 12.23.1 Henan Grand Biopharma Company Information 12.23.2 Henan Grand Biopharma Human Vaccine Product Offered 12.23.3 Henan Grand Biopharma Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.23.4 Henan Grand Biopharma Main Business Overview 12.23.5 Henan Grand Biopharma Latest Developments 12.24 ZhongKe Biopharm 12.24.1 ZhongKe Biopharm Company Information 12.24.2 ZhongKe Biopharm Human Vaccine Product Offered 12.24.3 ZhongKe Biopharm Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.24.4 ZhongKe Biopharm Main Business Overview 12.24.5 ZhongKe Biopharm Latest Developments 12.25 Zhuoyi Biological 12.25.1 Zhuoyi Biological Company Information 12.25.2 Zhuoyi Biological Human Vaccine Product Offered 12.25.3 Zhuoyi Biological Human Vaccine Sales, Revenue, Price and Gross Margin (2019-2021) 12.25.4 Zhuoyi Biological Main Business Overview 12.25.5 Zhuoyi Biological Latest Developments 13 Research Findings and Conclusion

List of Tables Table 1. Human Vaccine Consumption CAGR by Region (2020-2026) & ($ Millions) Table 2. Major Players of Varicella Table 3. Major Players of Influenza Table 4. Major Players of Polio Table 5. Major Players of Hepatitis A Table 6. Major Players of Rabies Table 7. Major Players of BCG Table 8. Major Players of Hepatitis B Table 9. Major Players of Pertussis, Diphtheria, Tetanus Table 10. Major Players of Pneumococcal Table 11. Major Players of Rota vaccine Table 12. Global Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 13. Global Human Vaccine Sales Market Share by Type (2016-2021) Table 14. Global Human Vaccine Revenue by Type (2016-2021) & ($ million) Table 15. Global Human Vaccine Revenue Market Share by Type (2016-2021) Table 16. Global Human Vaccine Sale Price by Type (2016-2021) Table 17. Global Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 18. Global Human Vaccine Sales Market Share by Application (2016-2021) Table 19. Global Human Vaccine Value by Application (2016-2021) Table 20. Global Human Vaccine Revenue Market Share by Application (2016-2021) Table 21. Global Human Vaccine Sale Price by Application (2016-2021) Table 22. Global Human Vaccine Sales by Company (2019-2021) & (M Doses) Table 23. Global Human Vaccine Sales Market Share by Company (2019-2021) Table 24. Global Human Vaccine Revenue by Company (2019-2021) ($ Millions) Table 25. Global Human Vaccine Revenue Market Share by Company (2019-2021) Table 26. Global Human Vaccine Sale Price by Company (2019-2021) Table 27. Key Manufacturers Human Vaccine Producing Area Distribution and Sales Area Table 28. Players Human Vaccine Products Offered Table 29. Human Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2019-2021) Table 30. New Products and Potential Entrants Table 31. Mergers & Acquisitions, Expansion Table 32. Global Human Vaccine Sales by Region (2016-2021) (M Doses) Table 33. Global Human Vaccine Sales Market Share by Region (2016-2021) Table 34. Global Human Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 35. Global Human Vaccine Revenue Market Share by Region (2016-2021) Table 36. Americas Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 37. Americas Human Vaccine Sales Market Share by Country (2016-2021) Table 38. Americas Human Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 39. Americas Human Vaccine Revenue Market Share by Country (2016-2021) Table 40. Americas Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 41. Americas Human Vaccine Sales Market Share by Type (2016-2021) Table 42. Americas Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 43. Americas Human Vaccine Sales Market Share by Application (2016-2021) Table 44. APAC Human Vaccine Sales by Region (2016-2021) & (M Doses) Table 45. APAC Human Vaccine Sales Market Share by Region (2016-2021) Table 46. APAC Human Vaccine Revenue by Region (2016-2021) & ($ Millions) Table 47. APAC Human Vaccine Revenue Market Share by Region (2016-2021) Table 48. APAC Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 49. APAC Human Vaccine Sales Market Share by Type (2016-2021) Table 50. APAC Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 51. APAC Human Vaccine Sales Market Share by Application (2016-2021) Table 52. Europe Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 53. Europe Human Vaccine Sales Market Share by Country (2016-2021) Table 54. Europe Human Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 55. Europe Human Vaccine Revenue Market Share by Country (2016-2021) Table 56. Europe Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 57. Europe Human Vaccine Sales Market Share by Type (2016-2021) Table 58. Europe Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 59. Europe Human Vaccine Sales Market Share by Application (2016-2021) Table 60. Middle East & Africa Human Vaccine Sales by Country (2016-2021) & (M Doses) Table 61. Middle East & Africa Human Vaccine Sales Market Share by Country (2016-2021) Table 62. Middle East & Africa Human Vaccine Revenue by Country (2016-2021) & ($ Millions) Table 63. Middle East & Africa Human Vaccine Revenue Market Share by Country (2016-2021) Table 64. Middle East & Africa Human Vaccine Sales by Type (2016-2021) & (M Doses) Table 65. Middle East & Africa Human Vaccine Sales Market Share by Type (2016-2021) Table 66. Middle East & Africa Human Vaccine Sales by Application (2016-2021) & (M Doses) Table 67. Middle East & Africa Human Vaccine Sales Market Share by Application (2016-2021) Table 68. Key and Potential Regions of Human Vaccine Table 69. Key Application and Potential Industries of Human Vaccine Table 70. Key Challenges of Human Vaccine Table 71. Key Trends of Human Vaccine Table 72. Human Vaccine Distributors List Table 73. Human Vaccine Customer List Table 74. Global Human Vaccine Sales Forecast by Region (2021-2026) & (M Doses) Table 75. Global Human Vaccine Consumption Market Forecast by Region Table 76. Global Human Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 77. Global Human Vaccine Revenue Market Share Forecast by Region (2021-2026) Table 78. Americas Human Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 79. Americas Human Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 80. APAC Human Vaccine Sales Forecast by Region (2021-2026) & (M Doses) Table 81. APAC Human Vaccine Revenue Forecast by Region (2021-2026) & ($ millions) Table 82. Europe Human Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 83. Europe Human Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 84. Middle East & Africa Human Vaccine Sales Forecast by Country (2021-2026) & (M Doses) Table 85. Middle East & Africa Human Vaccine Revenue Forecast by Country (2021-2026) & ($ millions) Table 86. Global Human Vaccine Sales Forecast by Type (2021-2026) & (M Doses) Table 87. Global Human Vaccine Sales Market Share Forecast by Type (2021-2026) Table 88. Global Human Vaccine Revenue Forecast by Type (2021-2026) & ($ Millions) Table 89. Global Human Vaccine Revenue Market Share Forecast by Type (2021-2026) Table 90. Global Human Vaccine Sales Forecast by Application (2021-2026) & (M Doses) Table 91. Global Human Vaccine Sales Market Share Forecast by Application (2021-2026) Table 92. Global Human Vaccine Revenue Forecast by Application (2021-2026) & ($ Millions) Table 93. Global Human Vaccine Revenue Market Share Forecast by Application (2021-2026) Table 94. CNBG Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 95. CNBG Human Vaccine Product Offered Table 96. CNBG Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 97. CNBG Main Business Table 98. CNBG Latest Developments Table 99. Changsheng Life Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 100. Changsheng Life Human Vaccine Product Offered Table 101. Changsheng Life Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 102. Changsheng Life Main Business Table 103. Changsheng Life Latest Developments Table 104. Zhifei Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 105. Zhifei Human Vaccine Product Offered Table 106. Zhifei Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 107. Zhifei Main Business Table 108. Zhifei Latest Developments Table 109. ChengDa Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 110. ChengDa Bio Human Vaccine Product Offered Table 111. ChengDa Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 112. ChengDa Bio Main Business Table 113. ChengDa Bio Latest Developments Table 114. Kangtai Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 115. Kangtai Human Vaccine Product Offered Table 116. Kangtai Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 117. Kangtai Main Business Table 118. Kangtai Latest Developments Table 119. SINOVAC BIOTECH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 120. SINOVAC BIOTECH Human Vaccine Product Offered Table 121. SINOVAC BIOTECH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 122. SINOVAC BIOTECH Main Business Table 123. SINOVAC BIOTECH Latest Developments Table 124. Hissen Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 125. Hissen Human Vaccine Product Offered Table 126. Hissen Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 127. Hissen Main Business Table 128. Hissen Latest Developments Table 129. Walvax Biotechnology Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 130. Walvax Biotechnology Human Vaccine Product Offered Table 131. Walvax Biotechnology Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 132. Walvax Biotechnology Main Business Table 133. Walvax Biotechnology Latest Developments Table 134. GSK Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 135. GSK Human Vaccine Product Offered Table 136. GSK Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 137. GSK Main Business Table 138. GSK Latest Developments Table 139. SANOFI Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 140. SANOFI Human Vaccine Product Offered Table 141. SANOFI Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 142. SANOFI Main Business Table 143. SANOFI Latest Developments Table 144. Rong An Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 145. Rong An Human Vaccine Product Offered Table 146. Rong An Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 147. Rong An Main Business Table 148. Rong An Latest Developments Table 149. NuoCheng Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 150. NuoCheng Bio Human Vaccine Product Offered Table 151. NuoCheng Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 152. NuoCheng Bio Main Business Table 153. NuoCheng Bio Latest Developments Table 154. Hualan Bio Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 155. Hualan Bio Human Vaccine Product Offered Table 156. Hualan Bio Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 157. Hualan Bio Main Business Table 158. Hualan Bio Latest Developments Table 159. Tiantan biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 160. Tiantan biological Human Vaccine Product Offered Table 161. Tiantan biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 162. Tiantan biological Main Business Table 163. Tiantan biological Latest Developments Table 164. Changchun Baike Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 165. Changchun Baike Human Vaccine Product Offered Table 166. Changchun Baike Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 167. Changchun Baike Main Business Table 168. Changchun Baike Latest Developments Table 169. Adimmune Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 170. Adimmune Human Vaccine Product Offered Table 171. Adimmune Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 172. Adimmune Main Business Table 173. Adimmune Latest Developments Table 174. Zhongyianke Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 175. Zhongyianke Biotech Human Vaccine Product Offered Table 176. Zhongyianke Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 177. Zhongyianke Biotech Main Business Table 178. Zhongyianke Biotech Latest Developments Table 179. Bharat Biotech Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 180. Bharat Biotech Human Vaccine Product Offered Table 181. Bharat Biotech Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 182. Bharat Biotech Main Business Table 183. Bharat Biotech Latest Developments Table 184. Bavarian Nordic Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 185. Bavarian Nordic Human Vaccine Product Offered Table 186. Bavarian Nordic Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 187. Bavarian Nordic Main Business Table 188. Bavarian Nordic Latest Developments Table 189. Sanofi-Pasteur Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 190. Sanofi-Pasteur Human Vaccine Product Offered Table 191. Sanofi-Pasteur Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 192. Sanofi-Pasteur Main Business Table 193. Sanofi-Pasteur Latest Developments Table 194. Indian Immunologicals Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 195. Indian Immunologicals Human Vaccine Product Offered Table 196. Indian Immunologicals Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 197. Indian Immunologicals Main Business Table 198. Indian Immunologicals Latest Developments Table 199. KANGH Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 200. KANGH Human Vaccine Product Offered Table 201. KANGH Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 202. KANGH Main Business Table 203. KANGH Latest Developments Table 204. Henan Grand Biopharma Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 205. Henan Grand Biopharma Human Vaccine Product Offered Table 206. Henan Grand Biopharma Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 207. Henan Grand Biopharma Main Business Table 208. Henan Grand Biopharma Latest Developments Table 209. ZhongKe Biopharm Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 210. ZhongKe Biopharm Human Vaccine Product Offered Table 211. ZhongKe Biopharm Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 212. ZhongKe Biopharm Main Business Table 213. ZhongKe Biopharm Latest Developments Table 214. Zhuoyi Biological Basic Information, Human Vaccine Manufacturing Base, Sales Area and Its Competitors Table 215. Zhuoyi Biological Human Vaccine Product Offered Table 216. Zhuoyi Biological Human Vaccine Sales (M Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2019-2021E) Table 217. Zhuoyi Biological Main Business Table 218. Zhuoyi Biological Latest Developments List of Figures Figure 1. Picture of Human Vaccine Figure 2. Human Vaccine Report Years Considered Figure 3. Research Objectives Figure 4. Research Methodology Figure 5. Research Process and Data Source Figure 6. Global Human Vaccine Sales Growth Rate 2016-2026 (M Doses) Figure 7. Global Human Vaccine Revenue Growth Rate 2016-2026 ($ Millions) Figure 8. Human Vaccine Sales by Region (2021 & 2026) & ($ millions) Figure 9. Product Picture of Varicella Figure 10. Product Picture of Influenza Figure 11. Product Picture of Polio Figure 12. Product Picture of Hepatitis A Figure 13. Product Picture of Rabies Figure 14. Product Picture of BCG Figure 15. Product Picture of Hepatitis B Figure 16. Product Picture of Pertussis, Diphtheria, Tetanus Figure 17. Product Picture of Pneumococcal Figure 18. Product Picture of Rota vaccine Figure 19. Global Human Vaccine Sales Market Share by Type in 2020 Figure 20. Global Human Vaccine Revenue Market Share by Type (2016-2021) Figure 21. Human Vaccine Consumed in Adults Figure 22. Global Human Vaccine Market: Adults (2016-2021) & (M Doses) Figure 23. Human Vaccine Consumed in Children Figure 24. Global Human Vaccine Market: Children (2016-2021) & (M Doses) Figure 25. Global Human Vaccine Sales Market Share by Application (2016-2021) Figure 26. Global Human Vaccine Revenue Market Share by Application in 2020 Figure 27. Human Vaccine Revenue Market by Company in 2020 ($ Million) Figure 28. Global Human Vaccine Revenue Market Share by Company in 2020 Figure 29. Global Human Vaccine Sales Market Share by Regions (2016-2021) Figure 30. Global Human Vaccine Revenue Market Share by Region in 2020 Figure 31. Americas Human Vaccine Sales 2016-2021 (M Doses) Figure 32. Americas Human Vaccine Revenue 2016-2021 ($ Millions) Figure 33. APAC Human Vaccine Sales 2016-2021 (M Doses) Figure 34. APAC Human Vaccine Revenue 2016-2021 ($ Millions) Figure 35. Europe Human Vaccine Sales 2016-2021 (M Doses) Figure 36. Europe Human Vaccine Revenue 2016-2021 ($ Millions) Figure 37. Middle East & Africa Human Vaccine Sales 2016-2021 (M Doses) Figure 38. Middle East & Africa Human Vaccine Revenue 2016-2021 ($ Millions) Figure 39. Americas Human Vaccine Sales Market Share by Country in 2020 Figure 40. Americas Human Vaccine Revenue Market Share by Country in 2020 Figure 41. Americas Human Vaccine Sales Market Share by Type in 2020 Figure 42. Americas Human Vaccine Sales Market Share by Application in 2020 Figure 43. United States Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 44. Canada Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 45. Mexico Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 46. Brazil Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 47. APAC Human Vaccine Sales Market Share by Region in 2020 Figure 48. APAC Human Vaccine Revenue Market Share by Regions in 2020 Figure 49. APAC Human Vaccine Sales Market Share by Type in 2020 Figure 50. APAC Human Vaccine Sales Market Share by Application in 2020 Figure 51. China Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 52. Japan Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 53. Korea Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 54. Southeast Asia Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 55. India Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 56. Australia Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 57. Europe Human Vaccine Sales Market Share by Country in 2020 Figure 58. Europe Human Vaccine Revenue Market Share by Country in 2020 Figure 59. Europe Human Vaccine Sales Market Share by Type in 2020 Figure 60. Europe Human Vaccine Sales Market Share by Application in 2020 Figure 61. Germany Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 62. France Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 63. UK Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 64. Italy Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 65. Russia Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 66. Middle East & Africa Human Vaccine Sales Market Share by Country in 2020 Figure 67. Middle East & Africa Human Vaccine Revenue Market Share by Country in 2020 Figure 68. Middle East & Africa Human Vaccine Sales Market Share by Type in 2020 Figure 69. Middle East & Africa Human Vaccine Sales Market Share by Application in 2020 Figure 70. Egypt Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 71. South Africa Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 72. Israel Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 73. Turkey Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 74. GCC Country Human Vaccine Revenue Growth 2016-2021 ($ Millions) Figure 75. Channels of Distribution Figure 76. Distributors Profiles